Finance

Lists
531349:BOM
Panacea Biotec Ltd
359,70 INR
+0,93%
(+3,30) 1D
16-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 531349...
Open
354,35 INR
High
363,70 INR
Low
354,35 INR
Mkt. cap
22,05 млд
Avg. vol.
4,95 миң
Volume
1,47 миң
52-wk high
647,50 INR
52-wk low
293,10 INR
EPS
-1,16 INR
Shares outstanding
61,25 млн
No. of employees
2 миң
Open
354,35 INR
High
363,70 INR
Low
354,35 INR
Mkt. cap
22,05 млд
Avg. vol.
4,95 миң
Volume
1,47 миң
52-wk high
647,50 INR
52-wk low
293,10 INR
EPS
-1,16 INR
Shares outstanding
61,25 млн
No. of employees
2 миң
News stories
From web sources and news partners
Profile
Panacea Biotec is a global generic and specialty pharmaceutical and vaccine maker. It has principal offices in New Delhi, Mumbai, and Lalru. It has business interests in research, development, manufacturing and marketing of pharmaceutical formulations, vaccines, biosimilars, and natural products. Wikipedia
About Panacea Biotec Ltd
CEO-
Employees2,1 миң
Founded1984
Headquarters-
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,41 млд
1,65 млд
1,67 млд
2,00 млд
Cost of goods sold
589,40 млн
679,30 млн
763,93 млн
1,02 млд
Cost of revenue
589,40 млн
679,30 млн
763,93 млн
1,02 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
477,10 млн
405,30 млн
607,88 млн
441,60 млн
Operating expense
1,08 млд
939,70 млн
849,37 млн
1,00 млд
Total operating expenses
1,67 млд
1,62 млд
1,61 млд
2,02 млд
Operating income
-261,30 млн
32,90 млн
54,24 млн
-22,30 млн
Other non operating income
64,00 млн
22,80 млн
-149,85 млн
42,40 млн
EBT including unusual items
-191,70 млн
64,90 млн
-12,49 млн
35,70 млн
EBT excluding unusual items
-218,70 млн
37,20 млн
-47,72 млн
8,30 млн
Income tax expense
-51,60 млн
26,00 млн
-2,46 млн
13,70 млн
Effective tax rate
26,92%
40,06%
19,70%
38,38%
Other operating expenses
522,70 млн
449,90 млн
162,69 млн
480,30 млн
Net income
-139,20 млн
39,80 млн
5,13 млн
23,00 млн
Net profit margin
-9,86%
2,41%
0,31%
1,15%
Earnings per share
-
-
-
-
Interest and investment income
-
-
41,64 млн
-
Interest expense
-21,40 млн
-18,50 млн
-5,60 млн
-11,80 млн
Net interest expenses
-21,40 млн
-18,50 млн
36,04 млн
-11,80 млн
Depreciation and amortization charges
83,40 млн
84,50 млн
78,80 млн
79,00 млн
EBITDA
-177,60 млн
113,44 млн
129,51 млн
60,35 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору